Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-360,824
Closed -$26.9M 47
2025
Q4
$26.9M Sell
360,824
-625
-0.2% -$45.7K 2.96% 12
2025
Q3
$24.4M Sell
361,449
-1,017,410
-74% -$67.5M 2.48% 15
2025
Q2
$89.8M Buy
1,378,859
+297,526
+28% +$17.8M 7% 2
2025
Q1
$66.8M Buy
1,081,333
+931,920
+624% +$61.7M 4.39% 8
2024
Q4
$10.8M Sell
149,413
-15,270
-9% -$1.19M 0.43% 37
2024
Q3
$13.4M Sell
164,683
-148,184
-47% -$11.9M 0.45% 40
2024
Q2
$23.2M Sell
312,867
-352,580
-53% -$26.4M 0.71% 38
2024
Q1
$51.9M Buy
665,447
+323,519
+95% +$24.1M 1.36% 22
2023
Q4
$24.4M Buy
+341,928
New +$23.8M 0.56% 38

Other funds holding HOLX

Nuance Investments's HOLX Position: Q1 2026 in Review

Nuance Investments sold out of Hologic (HOLX) in Q1 2026, closing a stake of 360,824 shares — an estimated $26.9M sold.

Nuance Investments first reported a position in HOLX in Q4 2023 and held it in 9 quarters. The position peaked at $89.8M in Q2 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Nuance Investments reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Nuance Investments sold 360,824 Hologic shares in Q1 2026, an estimated $26.9M.
  • Nuance Investments first reported a position in Hologic in Q4 2023 and held it in 9 quarters.
  • Nuance Investments's Hologic position peaked at $89.8M in Q2 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Nuance Investments's 13F filing for Q1 2026, filed 8 May 2026.